Back to top

Piper Sandler Sticks to Its Buy Rating for Moderna (MRNA)

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Moderna, with a price target of $77.00. Tenthoff covers t...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Moderna, Inc. (MRNA)